Related Experiment Video
Updated: May 13, 2026
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
Anamaria Orza1, Olga Soriţău, Ciprian Tomuleasa
1Faculty of Chemistry and Chemical Engineering, Babes-Bolyai University, Cluj-Napoca, Romania.
Abstract:
The low rate of survival for patients diagnosed with glioblastoma may be attributed to the existence of a subpopulation of cancer stem cells. These stem cells have certain properties that enable them to resist chemotherapeutic agents and ionizing radiation. Herein, we show that temozolomide-loaded gold nanostructures are efficient in reducing chemoresistance and destroy 82.7% of cancer stem cells compared with a 42% destruction rate using temozolomide alone. Measurements of in vitro cytotoxicity and apoptosis indicate that combination with gold facilitated the ability of temozolomide, an alkylating drug, to alter the resistance of these cancer stem cells, suggesting a new chemotherapy strategy for patients diagnosed with inoperable recurrent malignant glioma.
Insights
Gold nanostructures loaded with temozolomide effectively target glioblastoma cancer stem cells, overcoming chemoresistance. This novel approach significantly enhances cancer stem cell destruction compared to temozolomide alone, offering a promising new strategy.
Area of Science:
- Oncology
- Nanomedicine
- Biochemistry
Background:
- Glioblastoma survival rates are low, potentially due to resistant cancer stem cells.
- These stem cells evade conventional therapies like chemotherapy and radiation.
Purpose of the Study:
- To investigate the efficacy of temozolomide-loaded gold nanostructures in overcoming cancer stem cell chemoresistance.
- To evaluate this combination as a novel therapeutic strategy for malignant glioma.
Main Methods:
- Utilized gold nanostructures loaded with temozolomide (TMZ).
- Assessed in vitro cytotoxicity and apoptosis.
- Compared cancer stem cell destruction rates between TMZ alone and TMZ-gold nanostructures.
Main Results:
- Temozolomide-loaded gold nanostructures destroyed 82.7% of cancer stem cells.
- Temozolomide alone resulted in a 42% destruction rate.
- Gold facilitated temozolomide's ability to overcome cancer stem cell resistance.
Conclusions:
- Temozolomide-loaded gold nanostructures represent a potent strategy against glioblastoma stem cells.
- This approach shows significant potential for treating inoperable recurrent malignant glioma.
- Combination therapy enhances drug efficacy by altering cancer stem cell resistance mechanisms.
